Company profile
Praxsyn Corporation
OTC: PXYN · Healthcare · Medical - Pharmaceuticals
PublicHQ Las Vegas, ILCIK 0001346973Reports USD
#398 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ 11GM —SS 44
v0.1 · 25/100 weight · pillars only
↑ operating margin, 3-yr revenue growth · ↓ return on equity, disclosure history
Methodology →Revenue TTM
$20.5M
Rev growth YoY (TTM)
-69.0%
Net income (FY)
-$12.4M
Employees
66
as of 2026-08-30
Market cap
$6.3k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$66.6M$66.6M2014
Net income-$12.4M-$12.4M2014
Operating income$26.1M$26.1M2014
Total assets$16.7M$16.7M2014
Liabilities$15.1M$15.1M2014
Equity$1.6M$1.6M2014
Revenue trend
FY2011 – FY2014 · USD
FY11
FY11
FY11
FY11
FY11
FY14
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Praxsyn Corporation’s revenue?
Praxsyn Corporation booked $66.6M in FY2014 revenue, growing 853% year over year — faster than 96% of Healthcare companies we track, at a -18.6% net margin.
Peers · Healthcare
Vir Biotechnology, Inc.48DIntellia Therapeutics, Inc.57CKura Oncology, Inc.39DPro-Dex, Inc.86AExagen Inc.55CAytu BioPharma, Inc.53DKey facts
CEOSean Daly
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersLas Vegas, IL
ExchangeOTC: PXYN
Employees66
IPO date2010-08-16
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.